Eleber

Eleber (Cabazitaxel) is an intravenous medication used for certain types of cancer treatment. This chemotherapy drug is designed to target and slow the growth of cancer cells.

Eleber is primarily used in the treatment of advanced prostate cancer. It works by interfering with the division of cancer cells, helping to slow their growth and spread. This medication is often considered when other treatments have not been effective.

Common effects of Eleber may include fatigue, nausea, and a lowered white blood cell count. Some patients may also experience hair loss or changes in appetite. These effects can vary widely among individuals.

Eleber should be administered under the supervision of a healthcare professional. It is important to discuss any existing medical conditions or allergies before starting treatment. Regular monitoring may be required during therapy.

Eleber may interact with other medications, including those that affect the liver or immune system. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions.